RAPTOR PHARMACEUTICAL INC has a total of 38 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Republic of Korea and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are AMYLIN PHARMACEUTICALS LLC, SYNERGY PHARMACEUTICALS INC and UNIV OF CONNECTICUT HEALTH CENTER.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Republic of Korea | 5 | |
#3 | China | 4 | |
#4 | Hong Kong | 4 | |
#5 | United States | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 4 | |
#7 | Australia | 2 | |
#8 | Canada | 2 | |
#9 | Japan | 2 | |
#10 | Mexico | 2 | |
#11 | Taiwan | 2 | |
#12 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Environmental technology | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Electrotherapy | |
#5 | Climate change adaptation technologies | |
#6 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Zankel Todd C | 24 |
#2 | Starr Christopher M | 24 |
#3 | Zankel Todd | 6 |
#4 | Demeule Michel | 5 |
#5 | Kennard Malcolm L | 5 |
#6 | Beliveau Richard | 5 |
#7 | Gabathuler Reinhard | 5 |
#8 | Yang Joseph | 5 |
#9 | Gabathuler Reinhardt | 4 |
#10 | Rioux Patrice | 2 |
Publication | Filing date | Title |
---|---|---|
TW201605434A | Use of cysteamine and derivatives thereof to treat mitochondrial diseases | |
KR20130025866A | Method for treating liver disorders with receptor associated protein (rap) peptide-fucosidase inhibitor conjugates | |
EP2132224A1 | Cyclic receptor-associated protein (rap) peptides | |
MX2009002893A | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates. | |
EP1945240A2 | Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof | |
WO2006138343A2 | Compositions comprising receptor - associated protein (rap) variants specific for lrp2 and uses thereof |